338 related articles for article (PubMed ID: 20183795)
1. Morphometric studies in human pancreatic cancer argues against the etiological role of type 2 diabetes in pancreatic cancer.
Saruc M; Iki K; Pour PM
Histol Histopathol; 2010 Apr; 25(4):423-32. PubMed ID: 20183795
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus in pancreatic cancer: is it a causal relationship?
Katsumichi I; Pour PM
Am J Surg; 2007 Oct; 194(4 Suppl):S71-5. PubMed ID: 17903450
[TBL] [Abstract][Full Text] [Related]
3. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases.
Iki K; Pour PM
J Histochem Cytochem; 2007 Feb; 55(2):111-8. PubMed ID: 16982850
[TBL] [Abstract][Full Text] [Related]
4. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects.
Tomita T
Islets; 2012; 4(3):223-32. PubMed ID: 22847497
[TBL] [Abstract][Full Text] [Related]
5. Early changes in islet hormone secretion in the hamster pancreatic cancer model.
Permert J; Herrington M; Kazakoff K; Pour PM; Adrian TE
Teratog Carcinog Mutagen; 2001; 21(1):59-67. PubMed ID: 11135321
[TBL] [Abstract][Full Text] [Related]
6. Amylin in pancreatic islets and pancreatic endocrine neoplasms.
Tomita T
Pathol Int; 2003 Sep; 53(9):591-5. PubMed ID: 14507315
[TBL] [Abstract][Full Text] [Related]
7. Islet amyloid polypeptide and calcitonin gene-related peptide immunoreactivity in amyloid and tumor cells of canine pancreatic endocrine tumors.
O'Brien TD; Westermark P; Johnson KH
Vet Pathol; 1990 May; 27(3):194-8. PubMed ID: 1972303
[TBL] [Abstract][Full Text] [Related]
8. Pathologic changes and glucose homeostasis according to expression of human islet amyloid polypeptide in type 2 diabetic patients.
Park JY; No HS; Ahn YR; Oh SH; Kim YS; Kim SY; Jang KT; Kim SW; Chung JH; Min YK; Heo JS; Choi SH; Choi DW; Lee MS; Lee MK; Kim JH; Kim KW
J Histochem Cytochem; 2010 Aug; 58(8):731-40. PubMed ID: 20421596
[TBL] [Abstract][Full Text] [Related]
9. Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo.
Mo XD; Gao LP; Wang QJ; Yin J; Jing YH
Lipids Health Dis; 2018 Mar; 17(1):42. PubMed ID: 29523142
[TBL] [Abstract][Full Text] [Related]
10. Dissociated insulin and islet amyloid polypeptide secretion from isolated rat pancreatic islets cocultured with human pancreatic adenocarcinoma cells.
Wang F; Adrian TE; Westermark G; Gasslander T; Permert J
Pancreas; 1999 May; 18(4):403-9. PubMed ID: 10231847
[TBL] [Abstract][Full Text] [Related]
11. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
O'Brien TD; Butler PC; Westermark P; Johnson KH
Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
[TBL] [Abstract][Full Text] [Related]
12. Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets.
Wang F; Adrian TE; Westermark GT; Ding X; Gasslander T; Permert J
Am J Physiol; 1999 Jan; 276(1):E19-24. PubMed ID: 9886946
[TBL] [Abstract][Full Text] [Related]
13. Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.
Tomita T
Islets; 2011; 3(4):166-74. PubMed ID: 21633185
[TBL] [Abstract][Full Text] [Related]
14. Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines.
Wang F; Larsson J; Abdiu A; Gasslander T; Westermark P; Adrian TE; Permert J
Int J Pancreatol; 1997 Apr; 21(2):157-64. PubMed ID: 9209957
[TBL] [Abstract][Full Text] [Related]
15. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
Westermark P; Andersson A; Westermark GT
Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
[TBL] [Abstract][Full Text] [Related]
16. Expression of islet amyloid polypeptide in fetal and adult porcine and human pancreatic islet cells.
Lukinius A; Korsgren O; Grimelius L; Wilander E
Endocrinology; 1996 Dec; 137(12):5319-25. PubMed ID: 8940352
[TBL] [Abstract][Full Text] [Related]
17. Islet amyloid polypeptide in the islets of Langerhans: friend or foe?
Gebre-Medhin S; Olofsson C; Mulder H
Diabetologia; 2000 Jun; 43(6):687-95. PubMed ID: 10907112
[TBL] [Abstract][Full Text] [Related]
18. Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of severely insulin-deficient diabetes mellitus with atrophied exocrine pancreas.
Sugawara K; Kobayashi T; Nakanishi K; Kajio H; Ohkubo M; Sugimoto T; Murase T; Itoh T; Hara M; Kosaka K
Pancreas; 1993 May; 8(3):312-5. PubMed ID: 8483872
[TBL] [Abstract][Full Text] [Related]
19. Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients.
Narita R; Toshimori H; Nakazato M; Kuribayashi T; Toshimori T; Kawabata K; Takahashi K; Masukura S
Diabetes Res Clin Pract; 1992 Jan; 15(1):3-14. PubMed ID: 1541232
[TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques.
Johnson KH; O'Brien TD; Hayden DW; Jordan K; Ghobrial HK; Mahoney WC; Westermark P
Am J Pathol; 1988 Jan; 130(1):1-8. PubMed ID: 3276206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]